VIRCHOW GROUP

Company Profile
VIRCHOW GROUP

Virchow Group, India manufactures APIs, intermediates and Biotech FDFs. Group companies hold cGMP approvals from USFDA, KFDA, EU and CEPs. APIs include Sulfamethoxazole, Sulfanilamide, Sulfasalazine, Sulfadiazine, sulfapyridine, Trimethoprim, Telmisartan, Olmesartan, Ranitidine, Cephalosporins (Oral and Sterile), Sildenafil, Itraconazole, pregabalin, Levetiracetam.  Intermediates include 7-AVCA and GCLE.

 

BIOTECH products include recombinant biosimilars, Blood Products (Albumin, Immunoglobulin), Probiotics, Oncology and cardiovascular products, Wound care products and Hyaluronic based medical devices. Virchow also undertakes contract manufacture of injectables (PFS, BFS, PEN cartridges) and topicals

more >

Year of Establishment: 1982

Total Assets(USD): 500,000 to 99,999,999

Total Number of Staff: more than 1000

Main Competitive Advantages: International Approvals/Standards,Experienced R&D Staff,Delivery Term,Production Capacity,Reputation,Quality Service

Other Competitive Advantages:

Patents and Copyrights:

Send your message to this supplier
  • From:
  • To:
    VIRCHOW GROUP
  • Send a Copy to this Email
  • Message:
    Upload Images / Files
    - Supports jpg, jpeg, png,
     gif, pdf, doc, docx,
     xls, xlsx, txt, rar and zip
    - Max upload 3 files;
     Max  total size: 3MB
    (0/3)

    Enter between 20 to 4,000 characters.This is not what you are looking for ? Post a Sourcing Request Now

  • Verification:
PharmaSources Customer Service